x

60 DEGREES PHARMACEUTICALS, INC. (Nasdaq:SXTP)

Health Care/Life Sciences • Pharmaceuticals
CIK 1946563
Company

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

Address
1025 Connecticut Avenue NW
Suite 1000
Washington, District of Columbia 20036
Employees
3
Stock Info
Close
$1.6200
Day Range
1.5700 - 1.7000
52 Week Range
1.5400 - 35.9940
Average volume
471.43K
Short Interest
23.79K (02/14/25)
% of Float Shorted
2.02%
Market Cap
$2.39M
Revenue
$253.57K
Net Income
-$3.7M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$44.6755
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Geoffrey S. Dow
Director
Xu Cheryl
Independent Director
Stephen Toovey
Independent Director
Paul Field
Independent Director
Charles W. Allen
SEC filings
DateFormEvent
18 Dec, 2024 4
9 Dec, 2024 4
21 Nov, 2024 4
14 Nov, 2024 10-Q
14 Nov, 2024 SC 13G
13 Nov, 2024 SC 13G/A
6 Nov, 2024 8-K
15 Oct, 2024 DEF 14A
8 Oct, 2024 8-K
2 Oct, 2024 PRE 14A
30 Sep, 2024 EFFECT
26 Sep, 2024 CORRESP
24 Sep, 2024 UPLOAD
19 Sep, 2024 S-3
11 Sep, 2024 4
6 Sep, 2024 8-K
28 Aug, 2024 8-K
14 Aug, 2024 10-Q
14 Aug, 2024 8-K
12 Aug, 2024 8-K
2 Aug, 2024 424B5
26 Jul, 2024 8-K
26 Jul, 2024 424B5
24 Jul, 2024 424B5
22 Jul, 2024 424B5
18 Jul, 2024 EFFECT
16 Jul, 2024 8-K
16 Jul, 2024 CORRESP
15 Jul, 2024 UPLOAD
12 Jul, 2024 S-3
9 Jul, 2024 8-K
27 Jun, 2024 8-K
12 Jun, 2024 8-K
30 May, 2024 DEF 14A
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
21 May, 2024 4
15 May, 2024 10-Q
7 May, 2024 SC 13G/A
3 May, 2024 PRE 14A
2 May, 2024 8-K
3 Apr, 2024 4
1 Apr, 2024 10-K
15 Mar, 2024 8-K
28 Feb, 2024 8-K
20 Feb, 2024 8-K
2 Feb, 2024 4
2 Feb, 2024 8-K
2 Feb, 2024 4
31 Jan, 2024 424B4
29 Jan, 2024 EFFECT
26 Jan, 2024 CORRESP
26 Jan, 2024 CORRESP
26 Jan, 2024 CORRESP
22 Jan, 2024 CORRESP
22 Jan, 2024 S-1
22 Jan, 2024 8-K
22 Jan, 2024 CORRESP
18 Jan, 2024 UPLOAD
16 Jan, 2024 8-K
12 Jan, 2024 DRS
18 Dec, 2023 3
18 Dec, 2023 SC 13G
20 Nov, 2023 10-Q
15 Nov, 2023 NT 10-Q
3 Nov, 2023 8-K
12 Oct, 2023 8-K
18 Sep, 2023 8-K
25 Aug, 2023 10-Q
17 Jul, 2023 8-K
13 Jul, 2023 424B4 IPO completed
12 Jul, 2023 4
12 Jul, 2023 4
12 Jul, 2023 CERT
11 Jul, 2023 3
11 Jul, 2023 3
11 Jul, 2023 3
11 Jul, 2023 SEC STAFF
11 Jul, 2023 3
11 Jul, 2023 3
11 Jul, 2023 EFFECT
11 Jul, 2023 3
11 Jul, 2023 3
11 Jul, 2023 3
11 Jul, 2023 3
7 Jul, 2023 CORRESP
7 Jul, 2023 CORRESP
27 Jun, 2023 8-A12B/A
27 Jun, 2023 CORRESP
27 Jun, 2023 CORRESP
27 Jun, 2023 CORRESP
22 Jun, 2023 CORRESP
16 Jun, 2023 CORRESP
16 Jun, 2023 CORRESP
14 Jun, 2023 8-A12B
14 Jun, 2023 8-A12B/A
14 Jun, 2023 CORRESP
12 Jun, 2023 CORRESP
12 Jun, 2023 CORRESP
8 Jun, 2023 S-1/A
8 Jun, 2023 CORRESP
6 Jun, 2023 UPLOAD
1 Jun, 2023 S-1/A
1 Jun, 2023 CORRESP
26 May, 2023 UPLOAD
24 May, 2023 D
19 May, 2023 S-1/A
19 May, 2023 CORRESP
8 May, 2023 UPLOAD
28 Apr, 2023 S-1/A
28 Apr, 2023 CORRESP
14 Apr, 2023 UPLOAD
14 Apr, 2023 SEC STAFF
3 Apr, 2023 S-1/A
3 Apr, 2023 CORRESP
8 Feb, 2023 UPLOAD
31 Jan, 2023 S-1
6 Jan, 2023 UPLOAD
23 Dec, 2022 DRSLTR
23 Dec, 2022 DRS/A
16 Dec, 2022 UPLOAD
5 Dec, 2022 DRS/A
5 Dec, 2022 DRSLTR
14 Nov, 2022 UPLOAD
18 Oct, 2022 DRS
Last update:2025-03-06 12:24:44.406728
60 DEGREES PHARMACEUTICALS, INC. by TradingView

Sign Up to Subscribe